Vasodilators have not been shown to be of value in all patients with chronic congestive heart failure due to left ventricular systolic dysfunction
- 15 August 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (4) , 435-438
- https://doi.org/10.1016/0002-9149(90)90700-b
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- The pharmacologic treatment of chronic congestive heart failure.Circulation, 1989
- Current therapy of the failing heart.Circulation, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.Heart, 1985
- Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failureJournal of the American College of Cardiology, 1985
- Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal studyPublished by Elsevier ,1985
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Evaluation of digitalis in cardiac failure.BMJ, 1982
- Long-Term Digitalis Therapy Improves Left Ventricular Function in Heart FailureNew England Journal of Medicine, 1980